Most Americans Are Happy With Health Insurance, Poll Finds

Most folks in the United States are happy with their health insurance, according to a new national poll, but many still struggle with denied claims, delays and rising costs.

The poll, conducted by NBC News Decision Desk and SurveyMonkey, found 82% of U.S. adults satisfied with their health insurance overall. About 1 in 3 said they...

Childhood Behavioral Problems Are Straining Family Finances, Experts Say

Kids’ behavioral problems account for a growing chunk of their health care costs, a new study says.

Mental health, substance use and other behavioral health care made up about 40% of all health expenditures for U.S. children in 2022, nearly twice as much as in 2011, according to findings published Dec. 15 in JAMA Pediatrics....

Risk-Based Breast Cancer Screening Outperforms Annual Mammograms, Clinical Trial Finds

Tailoring breast cancer screening to a woman’s individual cancer risk might work better than annual mammograms, a new study says.

Women had breast cancers caught at an earlier, more treatable stage when assigned to risk-based screening, compared to those who got annual mammograms regardless of personal risk, researchers reported Dec....

Large Review Finds Limited Proof Behind Many Medical Cannabis Uses

Medical marijuana is often seen as a safer, natural way to ease pain, anxiety or sleep issues. But a large new review suggests that for many of these uses, the science simply isn’t there.

It adds that a significant share of folks, roughly 30%, using cannabis for medical reasons may actually be at risk for addiction.

The review,...

COVID Vaccines Cut ER Visits for Children, CDC Reports

COVID-19 vaccines given to children last fall helped keep many out of emergency rooms (ER) and urgent care, new data shows.

The U.S. Centers for Disease Control and Prevention (CDC) reported that COVID vaccines reduced the risk of ER visits by 76% in kids under age 4 and by 56% in kids ages 5 to 17 during the first six months after vaccina...

FDA Approves Two New Antibiotics to Treat Drug-Resistant Gonorrhea

Doctors now have new tools to fight gonorrhea, a common sexually transmitted infection that has grown harder to treat over time.

The U.S. Food and Drug Administration (FDA) has approved two new antibiotics: Zoliflodacin and gepotidacin.

This is the first new major treatment for gonorrhea in decades.

On Friday, the FDA cleared z...